Irene M Reel Rodriguez, RN Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 111 State Route 35, Cliffwood, NJ 07721 Phone: 732-727-2555 Fax: 732-566-2101 |
Elizabeth Ianno, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 State Route 35, Cliffwood, NJ 07721 Phone: 347-729-8880 |
Kristina Maria Heredia I, Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 111 Nj-35, Cliffwood, NJ 07721 Phone: 732-812-5489 |
Juan Martinez Jr., Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 111 Nj Route 35s, Cliffwood, NJ 07721 Phone: 732-812-5489 |
Katie P Ratliff, RN Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 111 Route 35, Cliffwood, NJ 07721 Phone: 732-727-2555 Fax: 732-566-2101 |
Mrs. Donna Bondi, RN Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 111 State Route 36, Suite # 7, Cliffwood, NJ 07721 Phone: 848-702-0935 |
Mrs. Michelle Jessica Cypher, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Rte 35, Cliffwood, NJ 07721 Phone: 732-727-2555 Fax: 732-566-2101 |
Brandon Tessel, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Nj-35 South, Cliffwood, NJ 07721 Phone: 732-727-2555 |
Karen Anne Johnson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 State Route 35, Cliffwood, NJ 07721 Phone: 732-727-2555 Fax: 732-566-2101 |
News Archive
Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced it has dosed the first patient with recent onset of non-arteritic anterior ischemic optic neuropathy (NAION) in its ongoing Phase I study of QPI-1007, the Company's proprietary synthetic siRNA drug candidate for ocular neuroprotection.
Scientists at the Johns Hopkins Kimmel Cancer Center have identified two genes whose mutations appear to be linked to ovarian clear cell carcinoma, one of the most aggressive forms of ovarian cancer. Clear cell carcinoma is generally resistant to standard therapy.
Kaiser Health News provides a fresh take on health policy developments with "Roadblock?" By Signe Wilkinson.
The Sandra and Malcolm Berman Brain & Spine Institute at LifeBridge Health has been acknowledged for the exceptional quality of its stroke care with a Target: Stroke designation and two Get With The GuidelinesĀ®-Stroke Gold Plus Quality Achievement Awards from the American Heart Association/American Stroke Association.
› Verified 5 days ago